PSYC Begins Monetizing Psychedelic Spotlight Through Launch of PSYC Media Services
PSYC has launched PSYC Media Services, targeting the evolving medicinal psychedelics industry. The company reported a strong media presence with over 600K page views monthly for its site, Psychedelic Spotlight, and has formed media agreements with companies like Cybin and PsyBio Therapeutics. CEO David Flores emphasized the platform's revenue potential and the goal to establish PSYC Media Services as a leading service provider.
- Launch of PSYC Media Services aimed at the medicinal psychedelics sector.
- Monthly page views for Psychedelic Spotlight exceed 600K, indicating strong market interest.
- Successful media agreements with notable companies like Cybin and PsyBio Therapeutics.
- None.
PSYC Aims to Become Premiere Media Services Provider for Medicinal Psychedelics Industry
LAKE OSWEGO,OR, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a leading publicly traded digital media company within the emerging sector of medicinal psychedelics, is pleased to announce the Company’s recent launch of PSYC Media Services, which offers a variety of paid media-driven service offerings designed specifically for the growing number of companies operating within the emerging medicinal psychedelics industry.
Fueled by the significant media presence PSYC has established for Psychedelic Spotlight throughout the industry, and which the Company believes is best highlighted by the more than 600K page views the site is generating each month, along with its top ranking on Google for “psychedelic news”, PSYC has begun dedicating more of its internal resources towards the expansion and solicitation of its growing suite of media service offerings.
And following the announcement of the initial launch of its paid media services in July, the Company contends it has been successful in executing media service agreements with multiple companies across the medicinal psychedelics industry such as Cybin, MindSet Pharma, and PsyBio Therapeutics to list a few. And according to the Company, their success in delivering and executing these services in recent months has played an integral role in helping them develop the framework for PSYC Media Services and developing what the Company believes is an effective action plan to maximize monetization opportunities across its Psychedelic Spotlight platform.
“Our ability to create any kind of revenue stream through Psychedelic Spotlight was, in my opinion, always dependent upon demonstrating its true value potential,” said Global Trac Solutions, Inc. CEO, David Flores. “Now that it boasts one of the most dedicated and impressive followings in the industry, coupled with the sensational content we have produced over the last year, I believe we have more than proven the value of it and have positioned it as such where we can most effectively begin tapping into its monetization capabilities. And just as we have earned our success in evolving Psychedelic Spotlight into the premiere news source for the medicinal psychedelics industry, I fully intend for us to establish PSYC Media Services as the premiere media services provider for our industry.”
To learn more about PSYC Media Services, please visit the site, or view the promotional video here.
About Global Trac Solutions, Inc. (OTCPink: PSYC)
At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.
PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, we believe investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.
We are dedicated to a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We contend that we are truly the right TRAC to follow.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19 and the success of the current vaccine distribution, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.
Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.
Corporate Contact:
Global Trac Solutions, Inc. (PSYC)
www.globaltracsolutions.com
(702) 239-1919
psyc@globaltracsolutions.com
OTCPINK: PSYC
FAQ
What is PSYC Media Services?
How many page views does Psychedelic Spotlight receive?
Which companies have partnered with PSYC for media services?
What is the main focus of Global Trac Solutions, Inc. (PSYC)?
